• ENGLISH
  • FRANCAIS
  • Services
    • Services Overview
    • Clinical Trial Operations
      • Protocol Development and Study Design
      • Feasibility and Study Start Up
      • Patient Recruitment
      • Project Management
      • Clinical Operations
      • Centralized Monitoring
      • Decentralized Clinical Trials (DCT)
      • Centralized eTMF
      • Medical Services
    • Regulatory and Drug Development Consulting
      • Clinical Strategy
      • Nonclinical
      • Chemistry, Manufacturing, and Controls (CMC)
      • Regulatory Affairs
      • GxP Strategy Consulting
      • Publishing and Submissions
      • Medical Writing
    • Government and Public Health Services
    • Biometrics
      • Biostatistics and Statistical Programming
      • Data Management
    • Clinical Pharmacology Modeling Simulation
      • Clinical Pharmacology Integrated Drug Development
      • Model Informed Dose & Drug Development (MIDD)
      • Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
      • DMPK and Translational Discovery and Development
  • Therapeutic Expertise
    • Therapeutic Expertise Overview
    • By Subject
      • Oncology and Hematology
      • Rare Diseases and Orphan Drugs
      • Infectious Disease and Vaccine
      • Cell and Gene Therapy
      • Central Nervous System
      • Autoimmune and Inflammation
      • Allergy and Asthma
    • By Phase
  • Company
    • About Us
    • History
    • News
    • Events
    • Leadership
    • Mission, Vision, Values
  • Resources
    • Resource Library
    • Blog
  • Careers
    • Careers Overview
    • Job Listings
    • CRA Academy and Fellows Program
  • Contact Us
    • Contact Us
    • Request for Proposal
  • ENGLISH
  • FRANCAIS
  • Services
    • Services Overview
    • Clinical Trial Operations
      • Protocol Development and Study Design
      • Feasibility and Study Start Up
      • Patient Recruitment
      • Project Management
      • Clinical Operations
      • Centralized Monitoring
      • Decentralized Clinical Trials (DCT)
      • Centralized eTMF
      • Medical Services
    • Regulatory and Drug Development Consulting
      • Clinical Strategy
      • Nonclinical
      • Chemistry, Manufacturing, and Controls (CMC)
      • Regulatory Affairs
      • GxP Strategy Consulting
      • Publishing and Submissions
      • Medical Writing
    • Government and Public Health Services
    • Biometrics
      • Biostatistics and Statistical Programming
      • Data Management
    • Clinical Pharmacology Modeling Simulation
      • Clinical Pharmacology Integrated Drug Development
      • Model Informed Dose & Drug Development (MIDD)
      • Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
      • DMPK and Translational Discovery and Development
  • Therapeutic Expertise
    • Therapeutic Expertise Overview
    • By Subject
      • Oncology and Hematology
      • Rare Diseases and Orphan Drugs
      • Infectious Disease and Vaccine
      • Cell and Gene Therapy
      • Central Nervous System
      • Autoimmune and Inflammation
      • Allergy and Asthma
    • By Phase
  • Company
    • About Us
    • History
    • News
    • Events
    • Leadership
    • Mission, Vision, Values
  • Resources
    • Resource Library
    • Blog
  • Careers
    • Careers Overview
    • Job Listings
    • CRA Academy and Fellows Program
  • Contact Us
    • Contact Us
    • Request for Proposal
  1. Home
  2. Services
  3. Clinical Pharmacology Modeling Simulation
  4. Model Informed Dose & Drug Development (MIDD)
  5. Modeling and Simulation
    • Concentration-QT (C-QT) Analysis
    • Physiologically Based Pharmacokinetic Modeling
    • Quantitative Systems Pharmacology

Modeling and Simulation

  • Model Informed Dose & Drug Development (MIDD)
  • Dose Translation, Rationale, and Justification
  • Bridging and Extrapolation Approaches
  • Modeling and Simulation

Modeling and simulation have become indispensable in drug development. The FDA and EMA have both included modeling and simulation among their highest priorities to support efficient drug development and facilitate regulatory decision making. Together, the information and insights gleaned from modeling and simulation provide not only opportunities for a more efficient drug development program, but they also provide key support for marketing application submissions.

Using modeling and simulation, existing data can be leveraged to provide critical insights on product safety and effectiveness as related to drug concentration. The knowledge gained from modeling can be used to inform clinical trial designs, predict trial outcomes, select appropriate dosing regimens, understand clinically relevant factors contributing to variability in exposure and/or response, predict the impact of formulation changes on drug performance, and much more.

Allucent’s expert team of pharmacometricians have experience across a wide array of modeling tools/techniques and build models tailored to guide your drug development program’s specific needs. As part of these services, our team will create a custom, model-informed drug development plan that will outline the spectrum of information available and recommend data to be collected during development to facilitate the selection of the most salient models for your compound and disease area. Our custom modeling plan will inform decisions, probability of success, dosing strategy, and design efficient trials along the entire development journey from candidate selection to registration and beyond. 

Modeling and Simulation Services:

  • Model-Informed Drug Development Plan
  • Population PK/PD, Exposure-Response Analysis
  • Dose Selection and Justification
  • Allometric Scaling
  • Physiologically Based Pharmacokinetics (PBPK)
  • Quantitative Systems Pharmacology (QSP)
  • Concentration QT (cQT) Modeling
  • In Vitro, In Vivo Correlation (IVIVC)
  • Comparator PK/PD Analysis, Model-based Meta-analysis (MBMA)
  • Clinical Trial Simulations (CTS)

Contact Us

Let us partner with your team on bringing new therapies to light. Get in touch to get started.

CONTACT US

  • Services
    • Clinical Trial Operations
    • Regulatory and Drug Development Consulting
    • Government and Public Health Services
    • Biometrics
    • Clinical Pharmacology Modeling Simulation
  • Therapeutic Expertise
    • Oncology and Hematology
    • Rare Diseases and Orphan Drugs
    • Infectious Disease and Vaccine
    • Cell and Gene Therapy
    • Central Nervous System
    • Autoimmune and Inflammation
    • Allergy and Asthma
  • Company
    • About Us
    • News
    • Events
  • Privacy Policy
  • English
  • Francais

© 2023 Allucent. All rights

North American Headquarters
2000 Centregreen Way
Suite 300
Cary, North Carolina 27513
+1 919-361-2286

United Kingdom Headquarters
1st Floor, One Station Square,
Bracknell, Berkshire
RG12 1QB United Kingdom
T: +44 (0) 1344 891121
F: +44 (0) 1344 890335

European Headquarters
Stationsplein Noord-Oost 438
1117 CL Schiphol
The Netherlands
+31 20-4350-580